secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001104659-25-026176
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals replaces auditor Marcum LLP with CBIZ CPAs after attest business acquisition
--------------------------------------------------------------------------------

- Marcum LLP resigned as auditor on March 18, 2025; CBIZ CPAs P.C. engaged effective immediately for FY 2025.
- Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.
- Marcum's FY 2023 and 2024 reports contained no adverse opinion, qualification, disagreements, or reportable events.
- Engagement approved by Audit Committee; Marcum provided agreement letter attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925026176/0001104659-25-026176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925026176/tm259900d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-026176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer